Earlier and slightly more frequent progression to M1d disease, the prognostically worst M1 substage based on the recent revision of the AJCC staging system [21], may in part account for the worse OS of patients with APC/CTNNB1 genetic aberrations and stage IV melanoma that we saw in the TCGA SKCM dataset. This evidence concerns the gene CTNNB1 and melanoma.